Preora Diagnostics is a medical technology company focused on commercializing low-cost, minimally invasive, highly sensitive and highly specific screening tests for the most common types of solid-tumor cancers. The tests are designed to be simple enough to be performed in a primary care physician’s office without any extensive preparation.
The entire Preora team approaches each day with a clear mission: save lives by revolutionizing early cancer detection. Our screening tools use proprietary technology – Partial Wave Spectroscopy (PWS) Nanocytology – to detect cellular changes at the nanoscale level. PWS-based tests may aid in risk assessment and early detection of cancers in high-risk, asymptomatic patients. Tests results may provide physicians with information that they need to encourage patients to comply with national screening guidelines for lung, colorectal and other solid-tumor cancers.